Intega has been sold to Nimbus
Lincoln International (“Lincoln”), is pleased to announce that Air Liquide Group, advised by Lincoln, has sold its shares in Intega GmbH (“Intega” or the “Company”) to a fund advised by Nimbus, a Dutch private equity firm focused on hands-on investments in European industrial companies.
Lincoln supported Air Liquide in this transaction as exclusive M&A advisor organizing a structured, bidding process including a broad selection of international potential buyers. The parties have agreed not to disclose further details of the transaction.
Intega is a specialist for the installation of ultra-high-purity (UHP) supply systems serving primarily the semiconductor and pharma industry. Lincoln succeeded in developing a strong equity story, positioning Intega as a highly differentiated specialist who will be able to fully harness the growth potential presented by the rapid development in the semiconductor and pharma industry.
Based on a good understanding of the semiconductor industry, Lincoln has successfully convinced potential investors of the business model’s sustainability despite a certain cyclicality being associated with semiconductors. Lincoln’s global technology group consistently advises in the industrial technology sector and recorded the sixth successful industrial technology transaction in 2018.
Nimbus will support Intega’s next phase of growth and enable the Company to deliver on its strategy and realize its full potential through a dedicated focus on growth and international expansion.
Intega is one of the leading providers of high purity media technologies in Europe. Its key products are gas supply systems, chemical supply and drain systems as well as water systems that meet the high purity and safety critical requirements of the semiconductor and pharma industries. Intega employs approximately 180 people and counts highly reputable customers such as ABB, Air Liquide, Bayer, Bosch, Carl Zeiss, Infineon and Osram among its customers.
Nimbus is a leading investment firm with offices in Zeist, Netherlands, and Munich, Germany. Nimbus specializes in providing equity capital to industrial companies with strong potential and revenues between Euro 10 and 500 million. Since its foundation in 1999, Nimbus has invested in more than 50 companies.
Meet our Senior Team
View More Transactions
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln is pleased to announce that it has advised Riello Investimenti SGR on the sale of Trafimet Group to Kemppi Oy
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical